{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:27:41Z","timestamp":1785940061766,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1124\/jpet.122.001399","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T22:57:40Z","timestamp":1677538660000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"385","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4615-043X","authenticated-orcid":false,"given":"Yohei","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kajikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozaburo","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001399_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.116.237933","article-title":"Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension","volume":"360","author":"Aiello","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001399_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08977199509028958","article-title":"Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats","volume":"12","author":"Arcot","year":"1995","journal-title":"Growth Factors"},{"key":"10.1124\/jpet.122.001399_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.2106007","article-title":"CX(3)C chemokine fractalkine in pulmonary arterial hypertension","volume":"165","author":"Balabanian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.122.001399_bib4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1378\/chest.126.4.1255","article-title":"Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension","volume":"126","author":"Benisty","year":"2004","journal-title":"Chest"},{"key":"10.1124\/jpet.122.001399_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/bjp.2008.278","article-title":"Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice","volume":"155","author":"Bruzzone","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001399_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.trsl.2015.09.007","article-title":"Leptin knockout attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting proliferation of pulmonary arterial smooth muscle cells","volume":"166","author":"Chai","year":"2015","journal-title":"Transl Res"},{"key":"10.1124\/jpet.122.001399_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","article-title":"Pathogenic mechanisms of pulmonary arterial hypertension","volume":"44","author":"Chan","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.122.001399_bib8","article-title":"Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001399_bib9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.chest.2021.10.010","article-title":"Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension","volume":"161","author":"Condon","year":"2022","journal-title":"Chest"},{"key":"10.1124\/jpet.122.001399_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The effects of increasing plasma concentrations of dexmedetomidine in humans","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.122.001399_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1213\/ANE.0b013e3182a15aa6","article-title":"The hemodynamic response to dexmedetomidine loading dose in children with and without pulmonary hypertension","volume":"117","author":"Friesen","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.122.001399_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"key":"10.1124\/jpet.122.001399_bib13","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/01.ATV.0000090130.85752.ED","article-title":"Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development","volume":"23","author":"Hao","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.122.001399_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/cvr\/cvt105","article-title":"Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354","volume":"99","author":"Hosokawa","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.122.001399_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12918-017-0439-8","article-title":"Gene expression profiles and signaling mechanisms in \u03b12B-adrenoceptor-evoked proliferation of vascular smooth muscle cells","volume":"11","author":"Huhtinen","year":"2017","journal-title":"BMC Syst Biol"},{"key":"10.1124\/jpet.122.001399_bib16","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","article-title":"Sotatercept for the Treatment of Pulmonary Arterial Hypertension","volume":"384","author":"Humbert","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001399_bib17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.122.001399_bib18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1172\/JCI35070","article-title":"Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents","volume":"119","author":"Izikki","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001399_bib19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.106.634709","article-title":"Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy","volume":"114","author":"Jasmin","year":"2006","journal-title":"Circulation"},{"key":"10.1124\/jpet.122.001399_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00246-015-1110-z","article-title":"A retrospective comparison of dexmedetomidine versus midazolam for pediatric patients with congenital heart disease requiring postoperative sedation","volume":"36","author":"Jiang","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1124\/jpet.122.001399_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1124\/jpet.122.001399_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/01586154-201305000-00028","article-title":"Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro","volume":"74","author":"Kawasaki","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1124\/jpet.122.001399_bib23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1124\/jpet.122.001399_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2220\/biomedres.29.189","article-title":"The effects of dexmedetomidine on human neutrophil apoptosis","volume":"29","author":"Kishikawa","year":"2008","journal-title":"Biomed Res"},{"key":"10.1124\/jpet.122.001399_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jphs.2019.06.006","article-title":"Systematic expression analysis of genes related to generation of action potentials in human iPS cell-derived cardiomyocytes","volume":"140","author":"Kodama","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.122.001399_bib26","doi-asserted-by":"crossref","first-page":"H1546","DOI":"10.1152\/ajpheart.00944.2011","article-title":"New mechanisms of pulmonary arterial hypertension: role of Ca2+ signaling","volume":"302","author":"Kuhr","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.122.001399_bib27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/jpet.114.221861","article-title":"Ranolazine reduces remodeling of the right ventricle and provoked arrhythmias in rats with pulmonary hypertension","volume":"353","author":"Liles","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001399_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.intimp.2017.10.030","article-title":"Dexmedetomidine promotes liver regeneration in mice after 70% partial hepatectomy by suppressing NLRP3 inflammasome not TLR4\/NF\u03baB","volume":"54","author":"Lv","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/jpet.122.001399_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2017.12.008","article-title":"The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4\/NF-\u03baB and PI3K\/Akt\/mTOR pathways","volume":"94","author":"Meng","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1124\/jpet.122.001399_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdermsci.2014.04.002","article-title":"Vasoconstriction and anti-inflammatory properties of the selective \u03b1-adrenergic receptor agonist brimonidine","volume":"75","author":"Piwnica","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1124\/jpet.122.001399_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2018.05.001","article-title":"Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model","volume":"204","author":"Qiu","year":"2018","journal-title":"Life Sci"},{"key":"10.1124\/jpet.122.001399_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/jpet.122.001399_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"10.1124\/jpet.122.001399_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.10842","article-title":"Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells","volume":"103","author":"Shibakura","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.122.001399_bib35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"key":"10.1124\/jpet.122.001399_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","article-title":"Interleukin-6 overexpression induces pulmonary hypertension","volume":"104","author":"Steiner","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/jpet.122.001399_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jclinane.2008.10.010","article-title":"Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis","volume":"21","author":"Tasdogan","year":"2009","journal-title":"J Clin Anesth"},{"key":"10.1124\/jpet.122.001399_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2009.11.062","article-title":"The alpha(2)-adrenoceptor agonist dexmedetomidine suppresses memory formation only at doses attenuating the perception of sensory input","volume":"629","author":"van Oostrom","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001399_bib39","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ALN.0000000000002401","article-title":"Midazolam and Dexmedetomidine Affect Neuroglioma and Lung Carcinoma Cell Biology In Vitro and In Vivo","volume":"129","author":"Wang","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.122.001399_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.122.001399_bib41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.reth.2020.03.001","article-title":"Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381\/LRRC4 \/SDF-1\/CXCR4 signaling pathway","volume":"14","author":"Xue","year":"2020","journal-title":"Regen Ther"},{"key":"10.1124\/jpet.122.001399_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1875-4597(09)60002-3","article-title":"Effects of dexmedetomidine on regulating pulmonary inflammation in a rat model of ventilator-induced lung injury","volume":"46","author":"Yang","year":"2008","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1124\/jpet.122.001399_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacbts.2018.07.007","article-title":"Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension","volume":"3","author":"Yoshida","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1124\/jpet.122.001399_bib02016","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/kjm2.12506","article-title":"Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1","volume":"38","author":"Zhang","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1124\/jpet.122.001399_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107576","article-title":"Pulmonary arterial hypertension specific therapy: The old and the new","volume":"214","author":"Zolty","year":"2020","journal-title":"Pharmacol Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524004336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:28:41Z","timestamp":1739971721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524004336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0022356524004336"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001399","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}